Searched for
NILOTINIB CAPSULES
Cipla targets $1 bn US revenue in FY27Cipla aims for $1 billion in US sales by FY27, offsetting Revlimid's patent expiry with new launches, particularly in respiratory generics ...25 Jul, 2025, 10.29 PM IST- Cipla shares in focus after U.S. FDA nod for Leukemia drugCipla share price: In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib...21 Feb, 2025, 08.59 AM IST
- Aurobindo Pharma shares rise 3% after subsidiary signs license for generic version of Nilotinib CapsulesShares of Aurobindo Pharma went up by 3% after the company announced that its subsidiary Eugia Pharma has signed a voluntary license with M...23 Jun, 2023, 01.41 PM IST
- Aurobindo Pharma arm signs pact with Medicines Patent Pool to develop anti-cancer drugIndia's Aurobindo Pharma has announced that its subsidiary Eugia Pharma Specialities has signed a voluntary sub-licensing agreement with Me...23 Jun, 2023, 12.50 PM IST
Load More
